Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Net Margin (2017 - 2025)

Historic Net Margin for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to 519.23%.

  • Arcus Biosciences' Net Margin fell 3275600.0% to 519.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 142.08%, marking a year-over-year decrease of 394200.0%. This contributed to the annual value of 109.69% for FY2024, which is 1527000.0% up from last year.
  • As of Q3 2025, Arcus Biosciences' Net Margin stood at 519.23%, which was down 3275600.0% from 400.0% recorded in Q1 2025.
  • Arcus Biosciences' Net Margin's 5-year high stood at 78.83% during Q4 2021, with a 5-year trough of 824.17% in Q3 2021.
  • Over the past 5 years, Arcus Biosciences' median Net Margin value was 259.96% (recorded in 2023), while the average stood at 339.5%.
  • Examining YoY changes over the last 5 years, Arcus Biosciences' Net Margin showed a top increase of 17726800bps in 2021 and a maximum decrease of -8270000bps in 2021.
  • Over the past 5 years, Arcus Biosciences' Net Margin (Quarter) stood at 78.83% in 2021, then plummeted by -350bps to 197.06% in 2022, then crashed by -33bps to 261.29% in 2023, then tumbled by -38bps to 361.54% in 2024, then plummeted by -44bps to 519.23% in 2025.
  • Its Net Margin was 519.23% in Q3 2025, compared to 400.0% in Q1 2025 and 361.54% in Q4 2024.